CRBP

CRBP

USD

Corbus Pharmaceuticals Holdings Inc. Common Stock

$11.250-0.880 (-7.255%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$12.130

Máximo

$12.168

Mínimo

$11.230

Volumen

0.56M

Fundamentos de la Empresa

Capitalización de Mercado

191.2M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

0.27M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $4.64Actual $11.250Máximo $20.77

Noticias Relacionadas

GlobeNewswire

Corbus Pharmaceuticals Announces Pricing of Public Offering

NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced the pricing of an underwritten public

Ver más
Corbus Pharmaceuticals Announces Pricing of Public Offering
GlobeNewswire

Corbus Pharmaceuticals Announces Proposed Public Offering

NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced that it plans to offer and sell shares

Ver más
Corbus Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025

Ver más
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.